英文摘要 |
Bronchiectasis is a chronic irreversible respiratory disease that causes frequent coughing, thick phlegm, and dyspnea. The design of this study is based on a simulated patient data registration form, including: segmental distribution of bronchiectasis, clinical symptoms, operation time, surgical indications, and surgical site. Surgical results of the patients: including the postoperative hospital stay, complications, and symptoms improvement and symptom relapsed one month after the operation. From 2009 to 2022, a total of 89 patients underwent thoracoscopic bronchiectasis lung resection, with an average age of 60.6 (±12.29) years, including 58 females (65.2%) and 41 males (34.8%). Frequent cough was the most prevalent symptom, reported in 79 patients (88.8%), followed by thick phlegm in 66 patients (74.2%), and hemoptysis in 49 patients (55.1%). Among the 89 patients, 58 (65.2%) underwent unilateral lung surgery, and 31 (34.8%) underwent simultaneous bilateral lung surgery. Operation time was 142.64±67.31 minutes for unilateral lung surgery, 249.52±87.2 minutes for bilateral lung surgery. The average postoperative hospital stays were 8.57 (±5.87) days. The majority of patients were discharged safely following surgery, with the exception of a 72-year-old male who underwent thoracoscopic lung resection and tracheostomy due to preoperative bronchiectasis-induced pyo-pneumothorax and respiratory distress. Unfortunately, he succumbed on the 11th day postoperatively. In conclusion, thoracoscopic lung resection is an indispensable method for the treatment of bronchiectasis. The incidence of postoperative hemoptysis is low. Even if the patient’s physical function is stable, it is quite safe to perform one-stage bilateral lung surgery. |